# Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients

> **NCT06458465** · NA · COMPLETED · sponsor: **Alexandria University** · enrollment: 60 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Curcumin
- **DRUG:** Pentoxifylline 400 MG

## Key facts

- **NCT ID:** NCT06458465
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06458465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06458465, "Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06458465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*